Yes, the obligation of marketing authorisation holders to submit the respective application for a variation to marketing authorisation in case of a change to SPC, PIL and/or labelling remains unchanged.
Home
/
Medicines
/
Marketing authorisation of pharmaceuticals
/
Details of marketing authorisation
/
Questions and answers on the amended Act on...
/
General question
/
Will the new procedure of processing...